Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy.

PLoS One · 2013 · PMC3871554 · PMID 24376766

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

FSGS-lesions occurred more frequently in the TSP-2 overexpressing group, but this effect did not reach statistical significance ( Fig. 3C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.